Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer

NCT02532114 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02532114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02532114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Lead sponsor
University of Washington
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2015
Completion date
November 30, 2017
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration levels of testosterone, castration-resistant prostate carcinoma, metastatic prostate carcinoma, recurrent prostate carcinoma, stage iv prostate adenocarcinoma